| Title: | Assessing the Causal Relationships Between Insulin Resistance and Hyperuricemia and Gout Using Bidirectional Mendelian Randomization |
| Journal: | Arthritis & Rheumatology |
| Published: | 26 Sep 2021 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/33982892/ |
| DOI: | https://doi.org/10.1002/art.41779 |
| URL: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568618 |
| Citations: | 72 (54 in last 2 years) as of 8 Aug 2024 |
Publication 4099
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
OBJECTIVE: Hyperuricemia is closely associated with insulin resistance syndrome (and its many cardiometabolic sequelae); however, whether they are causally related has long been debated. We undertook this study to investigate the potential causal nature and direction between insulin resistance and hyperuricemia, along with gout, by using bidirectional Mendelian randomization (MR) analyses.</p>
METHODS: We used genome-wide association data (n = 288,649 for serum urate [SU] concentration; n = 763,813 for gout risk; n = 153,525 for fasting insulin) to select genetic instruments for 2-sample MR analyses, using multiple MR methods to address potential pleiotropic associations. We then used individual-level, electronic medical record-linked data from the UK Biobank (n = 360,453 persons of European ancestry) to replicate our analyses via single-sample MR analysis.</p>
RESULTS: Genetically determined SU levels, whether inferred from a polygenic score or strong individual loci, were not associated with fasting insulin concentrations. In contrast, genetically determined fasting insulin concentrations were positively associated with SU levels (0.37 mg/dl per log-unit increase in fasting insulin [95% confidence interval (95% CI) 0.15, 0.58]; P = 0.001). This persisted in outlier-corrected (β = 0.56 mg/dl [95% CI 0.45, 0.67]) and multivariable MR analyses adjusted for BMI (β = 0.69 mg/dl [95% CI 0.53, 0.85]) (P < 0.001 for both). Polygenic scores for fasting insulin were also positively associated with SU level among individuals in the UK Biobank (P < 0.001). Findings for gout risk were bidirectionally consistent with those for SU level.</p>
CONCLUSION: These findings provide evidence to clarify core questions about the close association between hyperuricemia and insulin resistance syndrome: hyperinsulinemia leads to hyperuricemia but not the other way around. Reducing insulin resistance could lower the SU level and gout risk, whereas lowering the SU level (e.g., allopurinol treatment) is unlikely to mitigate insulin resistance and its cardiometabolic sequelae.</p>
14 Keywords
- Adult
- Aged
- Female
- Genetic Loci
- Gout
- Humans
- Hyperuricemia
- Insulin
- Insulin Resistance
- Male
- Mendelian Randomization Analysis
- Middle Aged
- Polymorphism, Single Nucleotide
- Uric Acid
7 Authors
- Natalie McCormick
- Mark J. O'Connor
- Chio Yokose
- Tony R. Merriman
- David B. Mount
- Aaron Leong
- Hyon K. Choi
Enabling scientific discoveries that improve human health